Nick Stone | Head of Global Investor Relations |
Emma Walmsley | Chief Executive Officer |
Iain Mackay | Chief Financial Officer |
Deborah Waterhouse | Chief Executive Officer, ViiV Healthcare |
Brian McNamara | Chief Executive Officer, GSK Consumer Health |
Luke Miels | Chief Commercial Officer |
Roger Connor | President, Vaccine and Global Health |
Hal Barron | Chief Scientific Officer |
Graham Parry | Bank of America Merrill Lynch |
James Gordon | JPMorgan Chase & Co |
Laura Sutcliffe | UBS Investment Bank |
Timothy Anderson | Wolfe Research, LLC |
Kerry Holford | Joh. Berenberg, Gossler& Co. KG |
Peter Welford | Jefferies LLC |
Iain Simpson | Barclays |
Mark Purcell | Morgan Stanley |
Simon Baker | Redburn |
Good afternoon, ladies and gentlemen, and welcome to the Analyst Call for the GSK First Quarter 2022 Results. I will now hand you over to Nick Stone, Head of Global Investor Relations, who will introduce today's session.
Thank you, operator. Hello, everyone. Welcome to our Q1 2022 conference call and webcast for investors and analysts.